Nuvigil and Psoriasis - a phase IV clinical study of FDA data
Summary:
Psoriasis is reported as a side effect among people who take Nuvigil (armodafinil), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Xyrem, and have Cataplexy.
The phase IV clinical study analyzes which people have Psoriasis when taking Nuvigil. It is created by eHealthMe based on reports of 22,424 people who have side effects when taking Nuvigil from the FDA, and is updated regularly.
What is Nuvigil?
Nuvigil has active ingredients of armodafinil. It is often used in narcolepsy. eHealthMe is studying from 23,669 Nuvigil users. Check the latest studies of Nuvigil.
What is Psoriasis?
Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 1,476 drugs and 1,694 conditions by eHealthMe. Check the latest studies of Psoriasis.
22,424 people reported to have side effects when taking Nuvigil.
Among them, 40 people (0.18%) have Psoriasis.

Among these 40 people:
How long have people been on Nuvigil when they have Psoriasis? *
- < 1 month: 75 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 25 %
- 10+ years: 0.0 %
What is the gender of people who have Psoriasis when taking Nuvigil? *
- female: 57.5 %
- male: 42.5 %
What is the age of people who have Psoriasis when taking Nuvigil? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 6.67 %
- 30-39: 6.67 %
- 40-49: 20.0 %
- 50-59: 6.67 %
- 60+: 60.0 %
What are other drugs people take besides Nuvigil? *
- Xyrem: 17 people, 42.50%
- Metformin: 9 people, 22.50%
- Lyrica: 7 people, 17.50%
- Zyrtec: 7 people, 17.50%
- Cosentyx: 5 people, 12.50%
- Aleve: 5 people, 12.50%
- Benadryl: 5 people, 12.50%
- Ritalin: 5 people, 12.50%
- Humira: 5 people, 12.50%
- Aspirin: 4 people, 10.00%
What are other side effects people have besides Psoriasis? *
- Rashes (redness): 7 people, 17.50%
- Skin Exfoliation (removal of the oldest dead skin cells): 5 people, 12.50%
- Dry Skin: 4 people, 10.00%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 10.00%
- High Blood Pressure: 4 people, 10.00%
- Diarrhea: 4 people, 10.00%
- Injection Site Pain: 3 people, 7.50%
- Pain: 3 people, 7.50%
- Joint Pain: 3 people, 7.50%
- Itching: 3 people, 7.50%
What are the existing conditions these people have? *
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 11 people, 27.50%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 5 people, 12.50%
- High Blood Pressure: 4 people, 10.00%
- Cardiac Failure Congestive: 3 people, 7.50%
- Sleep Apnea Syndrome: 3 people, 7.50%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 7.50%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 7.50%
- Type 2 Diabetes: 2 people, 5.00%
- Feeling Abnormal: 2 people, 5.00%
- Pain: 2 people, 5.00%
* Approximation only. Some reports may have incomplete information.
Do you take Nuvigil and have Psoriasis?
- Check whether Psoriasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Nuvigil:
- Nuvigil (23,669 reports)
Psoriasis treatments and more:
- Psoriasis (508,163 reports)
How severe was Psoriasis and when was it recovered:
Expand to all the drugs that have ingredients of armodafinil:
- Psoriasis and drugs with ingredients of armodafinil (34 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Nuvigil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Psoriasis:
- Psoriasis (1,476 drugs)
Browse all the conditions that are associated with Psoriasis:
- Psoriasis (1,694 conditions)
Related publications that referenced our studies
- Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
- Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
- Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
- Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on armodafinil (the active ingredients of Nuvigil) and Nuvigil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Mucinex cause Blood Pressure Fluctuation? - 12 seconds ago
- Drug interactions of Clofarabine and Tramadol - 36 seconds ago
- Drug interactions of Methocarbamol and Ibu - 39 seconds ago
- Could Stelara cause Furuncle? - 44 seconds ago
- Could Otrexup cause Fatigue? - 50 seconds ago
- Could Fluvoxamine Maleate cause Akathisia? - 54 seconds ago
- Could Promethazine cause Lymph Follicular Hypertrophy? - 54 seconds ago
- Could Disopyramide Phosphate cause Atrial Fibrillation Aggravated? - a minute ago
- Could Acetaminophen cause Binge Eating? - a minute ago
- Drug interactions of Irbesartan and Effexor Xr - a minute ago